Head and Neck - p53 Mutated

A Phase II Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (ECOG EA3132)

Please contact Jamie Ford or Caroline Holcomb at (520) 626-6800 for further information regarding our clinical trials.

An Institutional Review Board responsible for human subjects research at The University of Arizona reviewed this research project and found it to be acceptable, according to applicable state and federal regulations and University policies designed to protect the rights and welfare of participants in research.